Home Microbot Medical, Inc.

Microbot Medical, Inc.

Microbot Medical Demonstrates Significant Progress in 2020

The company believes it is well-positioned to leverage and capitalize upon this momentum through 2021, with plans to execute additional developmental, regulatory, and clinical goals.

Microbot Medical Closes Acquisition of Novel Technology from CardioSert Ltd.

5/28/18: “The completion of this exciting and value-added acquisition, combined with our existing capabilities, global IP and recent pre-clinical results is expected to allow us to deliver highly differentiated robotic products to address some of today’s most unmet medical needs,” commented Harel Gadot, Chief Executive Officer, President and Chairman.